Sarepta Therapeutics, Inc. (SRPT) Stock Overview
Explore Sarepta Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Sarepta Therapeutics, Inc. (SRPT)
Key Financials
Key Financials
Market Cap
2.1B
P/E Ratio
-13.96
EPS (TTM)
$-0.60
ROE
-0.10%
SRPT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Sarepta Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SRPT on the NASDAQ shows an RSI of 50.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Sarepta Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -13.96 and a market capitalization of 2.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of SRPT on the NASDAQ.